TrialPath
★ High blood pressure

High blood pressure clinical trials — recruiting now

There are 20+ hypertension studies currently recruiting participants across the US. Every eligibility criterion translated into plain English.

Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With Preeclampsia

NCT06893510 · Pre-Eclampsia, Maternal Health, Relaxation
Recruiting

Preeclampsia, affecting 2-8% of pregnancies globally, is a leading hypertensive disorder in pregnancy. It is clinically characterized by elevated blood pressure (≥140/90 mmHg) after the 20th gestational week, often accompanied by proteinuria and systemic complications such as thrombocytopenia, liver dysfunction, and cerebral symptoms. This condition poses significant risks for both maternal and fetal health, increasing the likelihood of organ damage, preterm birth, and long-term cardiovascular and neurodevelopmental complications. Non-pharmacological interventions, including relaxation techniques, have been explored for symptom management. Progressive muscle relaxation (PMR) has shown efficacy in reducing stress, anxiety, and blood pressure. Recently, virtual reality (VR)-based relaxation techniques have gained attention for enhancing stress relief and improving health outcomes. This study aims to compare the effects of VR-based PMR with in-person PMR on maternal and fetal outcomes in preeclamptic pregnancies.

PhaseNA
TypeInterventional
Age18 Years
WhereIstanbul, Turkey (Türkiye)
SponsorIstanbul University - Cerrahpasa
▾Tap for details
Apply

Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

NCT07070583 · Aorto Iliac Occlusive Disease, Blood Pressure
Recruiting

Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.

PhaseNA
TypeInterventional
Age18 Years
WhereArnhem, Netherlands
SponsorRijnstate Hospital
▾Tap for details
Apply

Topical Insulin for Glaucoma

NCT05206877 · Glaucoma
Recruiting

The purpose of this Phase 1 trial is to determine the safety over 1-2 months of topic sterile human recombinant insulin on subjects with optic neuropathies (glaucoma, ischecmic optic neuropathy, and optic disc drusen).

PhasePhase 1
TypeInterventional
Age18 Years
WherePalo Alto, California, United States
SponsorStanford University
▾Tap for details
Apply

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

NCT06802861 · Preeclampsia, Preeclampsia (PE), Preeclampsia (PE) Risk
Recruiting

This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.

Phase—
TypeObservational
Age18 Years – 45 Years
WhereKnoxville, Tennessee, United States
SponsorUniversity of Tennessee Graduate School of Medicine
▾Tap for details
Apply

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

NCT07063537 · Glaucoma Open-Angle
Recruiting

The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.

PhaseNA
TypeInterventional
Age18 Years
WhereHalifax, Nova Scotia, Canada
SponsorNova Scotia Health Authority
▾Tap for details
Apply

Intracranial PrEssure Time dOse (ImPETO)

NCT04459806 · Intracranial Hypertension, Traumatic Brain Injury, Subarachnoid Hemorrhage
Recruiting

The new Integra CereLink ICP monitor integrate the possibility of recording and displaying continuously the AUC (Pressure Time Dose, PTD) and other ICP derived variables and provide the possibility of evaluating the utility of this information at the bedside. It offers the opportunity to test in a standardized way the clinical value of the PTD computation in this setting. Therefore, this study aims to test clinically if PTD recorded continuously is associated to patients' outcome and to identify a threshold of PTD associated with the transition from good to negative outcomes.

Phase—
TypeObservational
Age18 Years – 80 Years
WhereMonza, MB, Italy
SponsorUniversity of Milano Bicocca
▾Tap for details
Apply

Autonomic and Renal Contributions to Hypertension With ADT

NCT07848828 · Androgen Deprivation Therapy, Prostate Cancer, Hypertension
Recruiting

This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prostate cancer is the most common non-skin cancer in men, affecting approximately 1 in 8 American men and its primary treatment is through the use of ADT. However, ADT increases the likelihood of developing heart disease including high blood pressure. This study will determine if dysfunction of the nervous system and/or kidneys occurs in men undergoing ADT, as these systems play a significant role in control of blood pressure. The results from this study will help us understand the ways in which ADT contributes to heart disease and help us develop therapies to prevent heart disease in prostate cancer survivors.

PhasePhase 4
TypeInterventional
Age40 Years
WhereRichmond, Virginia, United States
SponsorVirginia Commonwealth University
▾Tap for details
Apply

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)

NCT07322133 · Hypotension and Shock, Pulmonary Hypertension of the Newborn (PPHN), Hypoxemic Respiratory Failure
Recruiting

This pilot randomized clinical trial compares dopamine and norepinephrine as first-line vasoactive therapies in term and late preterm neonates with pulmonary hypertension associated with hypoxemic respiratory failure and systemic hypotension. Systemic hypotension is a common and clinically significant complication of persistent pulmonary hypertension of the newborn (PPHN) and frequently requires vasopressor support to maintain adequate systemic perfusion. Dopamine is commonly used in this setting; however, prior animal experimental and clinical data suggest it may increase pulmonary vascular resistance, potentially worsening right ventricular afterload and hypoxemia. Norepinephrine may preferentially increase systemic vascular resistance with less effect on the pulmonary circulation. This study evaluates short-term hemodynamic and oxygenation responses following initiation of dopamine or norepinephrine.

PhasePhase 4
TypeInterventional
Age28 Days
WhereSacramento, California, United States
SponsorUniversity of California, Davis
▾Tap for details
Apply

Endoscopic Cyclophotocoagulation in Normal Tension Glaucoma

NCT04651530 · Normal Tension Glaucoma, Cataract
Recruiting

The purpose of this study is to assess whether endoscopic cyclophotocoagulation added to cataract surgery lowers intraocular pressure more than cataract surgery alone in patients with normal tension glaucoma.

PhaseNA
TypeInterventional
Age55 Years – 100 Years
WhereHelsinki, Finland
SponsorHelsinki University Central Hospital
▾Tap for details
Apply

Repeated Far Infrared Sauna Bathing in Adults With Obesity

NCT07158047 · Obesity (Disorder)
Recruiting

This is a clinical trial to determine if 30 sessions of far infrared sauna bathing can improve cardiovascular and metabolic function in adults with obesity.

PhaseNA
TypeInterventional
Age18 Years – 59 Years
WhereEugene, Oregon, United States
SponsorUniversity of Oregon
▾Tap for details
Apply

Sleep and Arterial Function in Hypertensive Patients With Poor Sleep Quality

NCT07789535 · Hypertension, Poor Sleep Quality, Insomnia
Recruiting

This prospective, parallel-group randomised controlled trial evaluates whether cognitive-behavioural therapy for insomnia (CBT-I) improves arterial function and psychological and cognitive outcomes in hypertensive patients with poor sleep quality. Adults aged 18-70 with controlled hypertension and poor baseline sleep quality (sleep efficiency \<=85%) are randomised 1:1 to CBT-I (four weekly 60-minute sessions) or passive sleep education. The primary outcomes are change from baseline in pulse wave velocity and central arterial pressure at 12 months. Secondary outcomes include blood pressure, depressive symptoms, perceived stress, cognitive complaints, and sleep quality, assessed at baseline, 1, 6, and 12 months.

PhaseNA
TypeInterventional
Age18 Years – 70 Years
WhereGuimarães, Braga District, Portugal
SponsorUnidade Local de Saúde do Alto Ave, EPE
▾Tap for details
Apply

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension

NCT07728630 · Hypertension, Endothelial Function
Recruiting

Hypertension is associated with endothelial dysfunction, an early event in the development of cardiovascular disease. Endothelial extracellular vesicles (EEVs) have emerged as promising biomarkers of endothelial activation and vascular injury; however, their relationship with blood pressure and microvascular endothelial function in untreated hypertension remains insufficiently understood. This observational case-control study aims to compare circulating EEV concentrations between normotensive adults and adults with newly diagnosed, untreated primary hypertension. In addition, the study will investigate the associations between EEV levels, blood pressure, microvascular endothelial function assessed by laser Doppler flowmetry, and established circulating biomarkers of endothelial activation. The findings may improve understanding of the role of EEVs in early hypertension and support their potential use as non-invasive biomarkers of endothelial dysfunction and cardiovascular risk.

Phase—
TypeObservational
Age18 Years
WhereOsijek, Croatia
SponsorJosip Juraj Strossmayer University of Osijek
▾Tap for details
Apply

Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase

Recruiting

This study is aimed at patients suffering from recently discovered intracranial hypertension, caracterized by visual loss, chronic headache and/or tinnitus. The goal is to evaluate if stenting of a specific vein in the brain could decrease the hypertension and improve associated symptoms. Patients will be randomly assigned in either best medical care group (recommended medication associated with weight loss) or interventional group (best medical car + stenting of the specific vein) and will undergo specific follow-up visits after 1, 3 and 12 months.

PhaseNA
TypeInterventional
Age18 Years
WhereMontpellier, France + 2 more
SponsorUniversity Hospital, Montpellier
▾Tap for details
Apply

Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine

NCT06059144 · Stroke, Acute, Stroke, Ischemic
Recruiting

PRESSURE is a multicenter, prospective, randomized, open, blinded end-point assessed (PROBE) trial, that aims to evaluate the efficacy and safety of drug-induced hypertension using peripheral dilute norepinephrine, in patients with acute ischemic stroke in a perforating artery territory and experiencing early neurological deterioration.

PhasePhase 3
TypeInterventional
Age18 Years
WhereBordeaux, France
SponsorUniversity Hospital, Bordeaux
▾Tap for details
Apply

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

NCT07561034 · Pulmonary Hypertension, Interstitial Lung Disease
Recruiting

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. Participants will complete a defined exercise regimen over a 16-week period, and functional capacity and patient reported outcomes will be assessed at baseline and after the intervention. The study aims to determine whether a home-based exercise approach is feasible and associated with improvements in functional performance.

PhaseNA
TypeInterventional
Age18 Years
WhereRochester, New York, United States
SponsorUniversity of Rochester
▾Tap for details
Apply

A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital

Recruiting

The goal of this clinical trial is to compare the short-term efficacy and safety of selective laser trabeculoplasty (SLT) to 0.005% latanoprost eye drops in lowering intraocular pressure (IOP) as primary therapy in treatment-naïve patients diagnosed as early to moderate primary open-angle glaucoma(POAG) or ocular hypertension (OHT) in the Lagos State University Teaching Hospital, Ikeja. The main questions it aims to answer are: 1. Will Selective Laser Trabeculoplasty be an equally effective treatment option compared with 0.005% Latanoprost eyedrops in reducing Intraocular Pressure when used alone as first-line therapy in Nigerian patients with POAG and OHT? 2. Will Selective Laser Trabeculoplasty record a similar safety profile compared with 0.005% Latanoprost when used independently as a primary therapy? 3. How will the quality of life of patients who undergo Selective Laser Trabeculoplasty treatment compare with patients on 0.005% Latanoprost eyedrops? Participants will be randomized to one of the two intervention groups. Group A(latanoprost group) will use 0.005% latanoprost eye drops every night at 2100hours(9.00pm) west African Time for 3 months. intraocular pressures will be monitored at intervals for a period of 3 months. Group B(SLT group) will have Laser treatment administered as a one-off treatment. intraocular pressures will be monitored at intervals for a period of 3 months. A record of side effects will be documented at each follow up visit

PhaseNA
TypeInterventional
Age18 Years – 90 Years
WhereIkeja, Lagos, Nigeria
SponsorLagos State Health Service Commission
▾Tap for details
Apply

Safety and Efficacy of FETO in CDH Phase III

NCT07187206 · Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia, Pulmonary Hypertension
Recruiting

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group

PhasePhase 3
TypeInterventional
Age18 Years – 50 Years
WhereCincinnati, Ohio, United States
SponsorChildren's Hospital Medical Center, Cincinnati
▾Tap for details
Apply

Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.

NCT06865235 · Open Angle Glaucoma (OAG)
Recruiting

Prospective, randomized, , double-blind, clinical trial, comparing the variation of intraocular pressure (IOP) of patients with mild or moderate primary open-angle glaucoma (OAG) and cataract divided into three groups. All study participants should be treated for the pathology with one or more hypotensive medications or, regardless of the number of drugs, when IOP is greater than 20 mmHg and less than 26 mmHg. The two-year follow-up should also compare the reduction in the number of medications used, reoperation rate, adverse effects, visual acuity, endothelial loss, induction of astigmatism, variation in IOP according to axial diameter of the eye, anterior chamber and age, in addition to the existence of change in the quality of life of patients in the postoperative period

PhaseNA
TypeInterventional
Age40 Years
WhereBelo Horizonte, Minas Gerais, Brazil
SponsorFaculdade de Ciências Médicas de Minas Gerais
▾Tap for details
Apply

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

NCT06925516 · Intrahepatic Cholangiocarcinoma (Icc)
Recruiting

The study aims to evaluate the efficacy and safety of Apatinib and Adebrelimab in Combination With chemotherapy in patients with advanced intrahepatic cholangiocarcinoma (ICC)

PhasePhase 2
TypeInterventional
Age18 Years – 75 Years
WhereGuangzhou, Guangdong, China
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
▾Tap for details
Apply

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

NCT04669548 · Intraabdominal Hypertension, Abdominal Compartment Syndrome, Acute Kidney Injury
Recruiting

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Phase—
TypeObservational
Age18 Years
WhereLos Angeles, California, United States + 8 more
SponsorPotrero Medical
▾Tap for details
Apply